Skip to content

Theravance Biopharma

Recent events

Recent events tied to this brand in public sources.

Back to profile2 entries

  1. 2020

    Theravance Biopharma appoints Deepika R. Pakianathan to its board

    Theravance Biopharma announced the appointment of Deepika R. Pakianathan, Ph.D. to its board of directors.

  2. 2020

    Theravance Biopharma prices public share offering

    Theravance Biopharma announced pricing of an underwritten public offering of 5.5 million ordinary shares at $27 per share; the offering was expected to close on February 14, subject to customary conditions.